Navigation Links
Laser Energetics to Integrate BrightStar(TM) Alexandrite Lasers in Medical and Dental Applications
Date:10/22/2007

MERCERVILLE, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Laser Energetics, Inc. (Pink Sheets: LNGT) announced today that the Company has entered into discussions with several medical and dental instrument suppliers regarding the integration of LEI's BrightStar(TM) Alexandrite lasers into their medical and dental products.

LEI's BrightStar(TM) Alexandrite laser's shorter fundamental tunable laser output and fiber optic beam delivery system can enhance medical and dental laser applications. The lasers may be used in the medical market for Photo Acoustic Imaging to detect certain types of cancer (such as breast cancer), Photo Dynamic Therapy for treatment of certain types of cancer (i.e., lung cancer), hair removal, tattoo removal, spider vein treatment, ophthalmic applications, and blood clot detection to name just a few applications. In addition, the lasers can be used in the dental market for low trauma decay treatment and teeth cleaning. There are many more medical and dental laser applications that LEI's BrightStar(TM) Alexandrite lasers can address.

The Company's BrightStar(TM) Alexandrite lasers, because of their compact design, are cheaper to build, and thus more cost effective and profitable to the practitioners using them.

These applications are in addition to the defense and homeland security markets already being addressed by the Company.

LEI's Medical Director, Dr. John T. LiVecchi, MD, FACS, stated "Lasers play a prominent role in the efficient delivery of healthcare in today's environment. Our BrightStar(TM) Alexandrite lasers are perfectly positioned to take a significant percentage of this large and growing market."

Robert D. Battis, Chairman and Chief Executive Officer of Laser Energetics, said, "Our goal is to identify as many uses as possible for the various BrightStar(TM) Alexandrite lasers. This will bring about cost reduction in manufacturing, enhanced market share and increased profit margins. LEI will strategically team with other companies who have already created an infrastructure to serve various markets, such as the medical/dental marketplace. We will strictly build lasers for them on an OEM basis, supporting their efforts. By concentrating our initial efforts on defense and security, and joint venturing or licensing technology for other markets, we expect to leverage our technology to maximize both sales and profits for the Company. We expect to be in a position to make several announcements regarding these developments in the near future.

About Laser Energetics, Inc.: LEI has and continues to develop a comprehensive and strategic laser product line that addresses applications in Industry, Science, Medicine and the Military. The Company has had a primary focus on its Alexandrite laser technology. These tunable solid state lasers are unique in that they can be conductively air cooled to compete favorably against water cooled lasers in many applications. In addition, these lasers have one of the greatest wavelength tuning ranges with a bandwidth of over 250nm. The company is pursuing markets that are diverse yet can use the same laser with their compact user friendly design. This laser technology provides a sustainable advantage over many other lasers because of their tune-ability, conductively air cooled operation, and their efficiency allowing these lasers to operate at 110 Volts as compared to other less efficient competitive lasers that are large and need 220 Volts to operate.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.


'/>"/>
SOURCE Laser Energetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Isolate and Analyze Total RNA from Cells Harvested by Laser Capture Microdissection
2. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation
3. Quality assurance of RNA derived from laser microdissected tissue samples obtained by the PALM MicroBeam System using the RNA 6000 Pico LabChip kit.
4. Working With Laser Capture Microdissection Samples
5. Laser Capture Microdissection (LCM) for the Analysis of Macrophage Gene Expression from Atherosclerotic Lesions
6. Laser Capture Microdissection (LCM) and Expression Profiling of Long-Range Projection Neurons
7. Differential Gene Expression Analysis of Pure Cell Populations from Frozen UterineTissue Using Laser Capture Microdissection (LCM) and cDNA Microarrays
8. Laser Capture Microdissection of muscle fiber populations and expression analysis by RT-PCR
9. Laser Capture Microdissection of Cells Labeled with Enhanced Green Fluorescent Protein
10. Alfalight receives $4.7M to produce next generation lasers
11. Alfalight finds Chinese distributor for high-power lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... with services spanning the full spectrum of drug and device development, and ... to pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) ...
(Date:1/19/2017)... -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a U.S. ... and inoperable solid tumor cancers, announced today that Dr. ... Bio, will present at the Phacilitate Immunotherapy World Conference ... Hotel in Miami, Florida . ... Therapeutic Approaches – Expanding the Reach of Cancer Immunotherapy ...
(Date:1/19/2017)... LAKES, N.J. , Jan. 18, 2017 BD (Becton, ... technology company, announced today that it will host a live webcast ... at 1 p.m. (ET). The webcast can be ... be available for replay through Tuesday, January 31, 2017. ... About BD BD ...
Breaking Biology Technology:
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/8/2016)... 8, 2016 Market Research Future published a half cooked ... Mobile Biometric Security and Service Market is expected to grow over ... Market Highlights: ... Mobile Biometric Security and Service ... increasing need of authentication and security from unwanted cyber threats. The ...
(Date:12/7/2016)... 7, 2016 According to a new market research report ... (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - Global ... from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at ... Continue Reading ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):